nsv4755256
- Organism: Homo sapiens
- Study:nstd199 (Quan et al. 2021)
- Variant Type:inversion
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:67,719,776
- Publication(s):Quan et al. 2021
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 145420 SVs from 148 studies. See in: genome view
Overlapping variant regions from other studies: 145947 SVs from 148 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nsv4755256 | Remapped | Good | GRCh38.p12 | Primary Assembly | First Pass | NC_000009.12 | Chr9 | 200,777 | 67,920,552 |
| nsv4755256 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000009.11 | Chr9 | 200,777 | 70,835,468 |
Variant Call Information
| Variant Call ID | Type | Method | Analysis |
|---|---|---|---|
| nssv16292044 | inversion | Sequencing | Split read mapping |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nssv16292044 | Remapped | Good | NC_000009.12:g.200 777_67920552inv | GRCh38.p12 | First Pass | NC_000009.12 | Chr9 | 200,777 | 67,920,552 |
| nssv16292044 | Submitted genomic | NC_000009.11:g.200 777_70835468inv | GRCh37 (hg19) | NC_000009.11 | Chr9 | 200,777 | 70,835,468 |